Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-07 Tax Withholding | 2024-04-09 7:27 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 585 | $2.29 | 164,383 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-15 5:16 pm | N/A 2031-03-12 | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 125,000 | $0 | 187,113 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 6:43 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 381 | $3.39 | 164,968 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 9:22 pm | N/A 2030-06-08 | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 46,155 | $0 | 227,462 (Direct) | View |
| 2023-04-07 Tax Withholding | 2023-04-10 7:41 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 480 | $0 | 120,154 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 7:36 pm | N/A 2030-03-01 | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 11,538 | $0 | 151,017 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 5:20 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 96,310 | $0 | 108,136 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 4:06 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 5,913 | $0 | 35,477 (Direct) | View |
| 2022-04-08 Option Award | 2022-04-12 4:06 pm | N/A 2029-04-07 | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 23,651 | $42.28 | 35,477 (Direct) | View |
Ownership | 2022-03-25 3:17 pm | N/A N/A | Emergent BioSolutions Inc. | EBS | Glessner Coleen EVP, Quality & Ethics, and CPL | 0 | $0 | 0 (Direct) | View |